Jianqing She1, Jing Zhou2, Zhan Hu3, Yulong Xia2. 1. Department of Cardiovascular, First Affiliated Hospital of Medical College, Xi'an Jiaotong University Xi'an, PR China ; Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education Xi'an, PR China. 2. Department of Cardiovascular Medicine, First Hospital of Peking University Beijing, PR China. 3. Peking Union Medical College Hospital Beijing, PR China.
Abstract
OBJECTIVE: To observe the atrial capture management in an atrial threshold monitoring algorithm. By calculating the enabling rate of the atrial threshold monitoring algorithm and comparing atrial thresholds measured automatically and manually, we evaluate its safety, reliability and applicability in clinical practice. METHODS AND RESULTS: Data were collected at implant, start of atrial threshold monitoring, visits scheduled 1 month, 2 months and 4 months thereafter, and upon notification of adverse events. Atrial threshold monitoring algorithm was enabled in 94 patients, while in 38 not, indicating an enabling rate of 71.2%. Causes of the unsuccessful attempts to enable automatic atrial threshold include tachycardia (2, 5.3%), and atrial safety margin not met (36, 94.7%). A total of 88 pairs of atrial thresholds measured automatically and manually were gained. The auto threshold was 0.528 ± 0.270 V, and the manual threshold was 0.580 ± 0.223 V. There is a strict correlation between the automatic measurements and those conducted manually by the physician with a P < 0.05. No significant differences were observed during the 1-month, 2-month and 4-month follow-up. CONCLUSION: Atrial threshold monitoring algorithm is safe, reliable and applicable over time. Atrial threshold monitoring tested atrial threshold was demonstrated to be clinically equivalent to the manual atrial threshold test. The addition of atrial threshold monitoring will benefit the patients by reducing energy cost and enhancing pacemaker safety.
OBJECTIVE: To observe the atrial capture management in an atrial threshold monitoring algorithm. By calculating the enabling rate of the atrial threshold monitoring algorithm and comparing atrial thresholds measured automatically and manually, we evaluate its safety, reliability and applicability in clinical practice. METHODS AND RESULTS: Data were collected at implant, start of atrial threshold monitoring, visits scheduled 1 month, 2 months and 4 months thereafter, and upon notification of adverse events. Atrial threshold monitoring algorithm was enabled in 94 patients, while in 38 not, indicating an enabling rate of 71.2%. Causes of the unsuccessful attempts to enable automatic atrial threshold include tachycardia (2, 5.3%), and atrial safety margin not met (36, 94.7%). A total of 88 pairs of atrial thresholds measured automatically and manually were gained. The auto threshold was 0.528 ± 0.270 V, and the manual threshold was 0.580 ± 0.223 V. There is a strict correlation between the automatic measurements and those conducted manually by the physician with a P < 0.05. No significant differences were observed during the 1-month, 2-month and 4-month follow-up. CONCLUSION: Atrial threshold monitoring algorithm is safe, reliable and applicable over time. Atrial threshold monitoring tested atrial threshold was demonstrated to be clinically equivalent to the manual atrial threshold test. The addition of atrial threshold monitoring will benefit the patients by reducing energy cost and enhancing pacemaker safety.
Authors: Johannes Sperzel; Goran Milasinovic; Timothy W Smith; Hardwin Mead; Johan Brandt; Wesley K Haisty; J Russell Bailey; Marc Roelke; Jay Simonson; Jennifer Englund; Eric Farges; Steven Compton Journal: Heart Rhythm Date: 2005-11 Impact factor: 6.343